MetaCap

Rhythm Pharmaceuticals Statistics

NASDAQ: RYTMHealth CareBiotechnology: Pharmaceutical PreparationsUSD

112.36-4.44 (-3.80%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Rhythm Pharmaceuticals by the numbers

Rhythm Pharmaceuticals has a market capitalization of $7.79 billion based on 69.33M shares outstanding. With trailing EPS of $-2.91, Rhythm Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.6% above its 50-day average and 15.3% above its 200-day average.

Average daily trading volume is 1.10M shares, or about $123.1 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

RYTM valuation vs. peer median

RYTM compared with the median of 8 peer companies
MetricRYTMPeer medianDifference
Market cap$7.79B$7.46B+4%
Avg. volume1.10M1.58M-31%

Peer median across 8 companies: PTGX, SMMT, ALKS, KNSA, AMRX, PRAX, CYTK, CORT.

Valuation

Price / sales (latest FY)
41.05
EPS (TTM)
$-2.91

Price and trading

Previous close
116.80
Open
115.46
Day range
112.00 – 117.01
52-week range
74.50 – 122.20
52-week change
+10.44%
Beta
—
Volume
1.50M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
7.79B
Forward Pe
-86.55
Eps
-2.91
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
122.20
Week52 Low
74.50
Avg Volume
1.10M
Shares Outstanding
69.33M
Ma50
98.08
Ma200
97.45
Earnings Date
Nov 3, 2026
Pct From52w High
-8.05%
Pct From52w Low
50.82%

Related